Postpartum Hemorrhage

Postpartum hemorrhage (PPH) is defined as blood loss exceeding 500 mL following vaginal delivery or 1000 mL following cesarean delivery, occurring within 24 hours of delivery (primary PPH) or between 24 hours and 12 weeks postpartum (secondary PPH). It remains the leading cause of maternal mortality worldwide, accounting for approximately 27% of maternal deaths, with significantly higher rates in low-resource settings. The incidence of clinically significant PPH occurs in 1-5% of deliveries in developed nations, though massive transfusion requirements occur in approximately 0.1-0.2% of deliveries. Despite standardized definitions, clinical assessment of blood loss is notoriously inaccurate, with studies demonstrating that healthcare providers underestimate actual blood loss by 30-50%; therefore, a high index of suspicion and proactive management are essential. Understanding the pathophysiology, rapid recognition, and systematic approach to management are critical competencies for obstetric providers and can dramatically reduce maternal morbidity and mortality.

Postpartum hemorrhage occurs through disruption of hemostasis at the placental implantation site, a process that normally involves intricate interactions between vascular, platelet, and coagulation mechanisms. The gravid uterus undergoes fundamental anatomic and physiologic adaptations that predispose to hemorrhage when these protective mechanisms fail:

During normal placental separation (third stage of labor), the placenta implants in the decidua basalis with trophoblastic invasion through the myometrial layer. The placental bed contains approximately 80-100 spiral arteries that are remodeled during pregnancy from small muscular vessels into large-caliber, low-resistance channels that deliver 500-750 mL/min of maternal blood at term. When the placenta separates, these vessels are torn, creating raw placental surface area equivalent to 400-600 cm². Hemostasis at the placental site depends critically on uterine contraction, which compresses these open spiral arteries in a "living ligature" mechanism—essentially, myometrial contraction occludes bleeding vessels physically. Loss of effective uterine contraction (uterine atony) results in uncontrolled bleeding from these vessels, which is the mechanism underlying the most common cause of PPH.

The massive tissue injury from placental separation activates the extrinsic coagulation pathway through release of tissue factor (TF) from damaged decidual tissue and trophoblast. Tissue factor binds factor VII, initiating the TF-factor VIIa complex that activates factors X and II, generating thrombin. This localized thrombin generation occurs within the placental bed, where it activates platelets and converts fibrinogen to fibrin. However, the extensive vascular injury overwhelms local hemostatic mechanisms in the setting of uterine atony. Additionally, the gravid uterus contains elevated concentrations of endogenous anticoagulants, particularly tissue plasminogen activator (tPA), which are released into circulation during placental separation. This creates a milieu of both procoagulant and anticoagulant activity; when anticoagulant activity predominates (especially in the context of DIC triggered by massive hemorrhage), consumption of platelets and clotting factors accelerates, creating a pathological cycle.

Normal pregnancy induces a hypercoagulable state characterized by increased synthesis of fibrinogen (up to 400-600 mg/dL, nearly double non-pregnant levels), increased factors II, VII, VIII, IX, and X, and elevated von Willebrand factor. This adaptation protects against hemorrhage during placental separation but creates a paradoxical scenario: pregnancy appears "protected" coagulation-wise, yet PPH remains the leading cause of maternal death. The maternal blood volume expands by 40-50% during pregnancy (to approximately 5-6 liters), and while this expanded intravascular volume theoretically buffers acute blood loss, the expanded plasma volume masks the severity of hemorrhage—a parturient can lose 1-1.5 liters of blood (20-30% of blood volume) while maintaining relatively stable vital signs due to compensatory tachycardia and vasoconstriction. This represents a critical clinical pearl: vital signs may be deceptively reassuring in early PPH, delaying diagnosis and treatment.

In massive PPH, the combination of extensive placental separation, exposure of thromboplastic substances, and release of endogenous tPA can trigger systemic fibrinolytic activation and disseminated intravascular coagulation (DIC). In this pathological cascade, systemic thrombin generation consumes platelets and clotting factors while activating plasmin, which degrades fibrin and fibrinogen. The result is paradoxical bleeding despite apparent "activation" of coagulation—a phenomenon termed consumptive coagulopathy. Additionally, tissue plasminogen activator released from the endothelium during labor exceeds normal anticoagulant responses, driving excessive fibrinolysis. This mechanism explains why massive PPH is accompanied by falling fibrinogen levels, thrombocytopenia, and prolonged PT/aPTT despite the normally hypercoagulable state of pregnancy.

The "four T's" mnemonic encapsulates the major mechanisms and etiologies of postpartum hemorrhage: Tone (uterine atony), Tissue (retained placental tissue), Trauma (birth canal injuries), and Thrombin (coagulation defects).

Uterine atony represents failure of the myometrium to contract effectively after placental delivery, preventing the "living ligature" compression of spiral arteries. Risk factors include: multiparity (especially grand multiparity ≥5 previous deliveries), prolonged labor (>12 hours), rapid labor, augmentation or induction with oxytocin (suggesting labor dystocia), general anesthesia (myometrial relaxant effects), chorioamnionitis/intrauterine infection, placental abruption, polyhydramnios or multiple gestation (uterine overdistension), fetal macrosomia, obesity, and maternal age >35. The mechanical explanation is that an overdistended uterus may not generate sufficient myometrial contractions, analogous to a stretched-out rubber band that cannot contract effectively. Systemic conditions that impair myometrial function include peripartum cardiomyopathy, severe sepsis, and magnesium sulfate use (used for seizure prophylaxis in preeclampsia; inhibits myometrial contractility). Magnesium sulfate deserves special emphasis as a commonly overlooked iatrogenic cause of atony—it blocks calcium influx necessary for myometrial contraction.

Incomplete placental delivery or retained products of conception (RPOC) prevent effective uterine contraction over the full placental bed. Risk factors include placenta accreta/increta/percreta (abnormal placentation with excessive trophoblastic invasion, increasingly common with prior uterine surgery or cesarean delivery), manual removal of placenta (increasing trauma and risk of leaving fragments), placental abruption (can fragment the placenta), and intrauterine adhesions (Asherman's syndrome). Additionally, metabolic acidosis and hypothermia from massive hemorrhage impair myometrial contractility, creating a vicious cycle where blood loss prevents clot formation and myometrial contraction, perpetuating further hemorrhage.

Lacerations of the cervix, vagina, perineum, or uterus can occur with vaginal delivery, especially with operative vaginal delivery (vacuum or forceps), rapid descent, or inadequate perineal support. Risk factors include primiparity, macrosomia, instrumental delivery, episiotomy (paradoxically associated with severe perineal trauma when extension occurs), and rapid descent in the second stage. Uterine rupture, while uncommon (0.03-0.15% of deliveries), is catastrophic and usually associated with prior uterine surgery (prior cesarean with classical incision being the highest risk), labor after cesarean attempt (TOLAC), uterotonic use in the setting of uterine scar, or obstructed labor. Fourth-degree perineal lacerations (involving anal sphincter) and cervical lacerations >2 cm are particularly prone to significant bleeding.

Inherited coagulation deficiencies (von Willebrand disease, hemophilia carriers, factor deficiencies), acquired coagulopathy from DIC, or anticoagulation therapy can predispose to PPH. Particularly important are von Willebrand disease (vWD), the most common inherited bleeding disorder (affects 0.6-1.3% of population), and the rarely diagnosed factor V deficiency. Preeclampsia with severe features and HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) cause thrombocytopenia and consumption coagulopathy. Anticoagulation therapy (warfarin, direct oral anticoagulants, heparin) requires careful peripartum management. Dilutional coagulopathy occurs with massive transfusion without adequate replacement of platelets and clotting factors—the "coagulopathy of massive transfusion" develops after replacement of >1-2 blood volumes with packed RBCs alone.

The clinical presentation of postpartum hemorrhage ranges from subtle, slowly progressive bleeding to acute, life-threatening hemorrhage, and the manifestations are driven by both the rate of blood loss and the adequacy of maternal compensation through sympathetic activation.

The most obvious presentation is vaginal bleeding greater than expected for the immediate postpartum period. However, clinicians must recognize that estimation of blood loss is notoriously inaccurate—studies demonstrate that visual estimation by experienced obstetric providers underestimates actual loss by 30-50%. A clot in a bedpan may appear much larger than its actual volume; conversely, blood soaked into drapes and pads may be overlooked. The practice of weighing soaked pads and drapes (where 1 gram increase equals approximately 1 mL of blood) is more objective than visual estimation but is infrequently used. The first clue to PPH may be saturation of a perineal pad in 15 minutes or less, or continuous trickling of blood despite attempts at uterine massage.

Early/compensated hemorrhagic shock: The parturient may report lightheadedness, dizziness, palpitations, or anxiety. The expanded blood volume of pregnancy masks hypovolemia—vital signs may remain stable despite 20-30% blood volume loss (1-1.5 liters). Tachycardia and tachypnea occur through sympathetic activation; blood pressure may remain normal until >30% blood volume loss. The physiologic basis is that catecholamine release from sympathetic activation causes peripheral vasoconstriction, redirecting blood flow to vital organs (heart, brain) at the expense of skin, kidneys, and GI tract.

Progressive/decompensated shock: With continued hemorrhage (>40% blood volume loss), compensatory mechanisms fail. The parturient develops obtundation, confusion, or loss of consciousness. Hypotension becomes manifest. Oliguria develops as renal perfusion falls below the threshold for glomerular filtration. Severe acidosis from tissue hypoxia and lactate accumulation occurs. This progression can occur over minutes to hours; PPH is deceptive because the transition from apparently stable patient to critically ill can be remarkably rapid.

The diagnosis of postpartum hemorrhage is primarily clinical, based on recognition of excessive bleeding in the immediate postpartum period. However, a systematic approach incorporating historical risk factors, clinical examination, and selective laboratory testing guides severity assessment and management decisions.

PPH is defined quantitatively as blood loss >500 mL after vaginal delivery or >1000 mL after cesarean delivery within 24 hours of delivery (primary PPH). However, this definition has limitations: (1) it is retrospective—one typically does not know the final blood loss until after delivery; (2) it does not account for individual patient factors (a 50-kg woman with hemoglobin 7 g/dL postpartum has suffered greater physiologic insult than a 100-kg woman with hemoglobin 10 g/dL); (3) visual estimation is inaccurate. Therefore, clinicians should employ a lower threshold for suspicion based on clinical context. The "obstetric hemorrhage alert" or "massive transfusion protocol" activation criteria (often defined as transfusion of >4 units of packed RBCs within 24 hours) can be used as an objective measure of severity and trigger for multidisciplinary involvement.

Systematic examination is essential to identify the source of bleeding and direct intervention:

Immediate stabilisation (simultaneous with diagnosis): ACOG's Practice Bulletin No. 183 on postpartum hemorrhage and the AIM/ACOG Obstetric Hemorrhage safety bundle frame PPH as a team response, not a sequence.

Cause-specific: repair lacerations; manual extraction/curettage for retained tissue; replace an inverted uterus before giving uterotonics, using a relaxant (nitroglycerin or terbutaline) if needed.